Creative Planning Has $351,000 Stake in PAREXEL International Corporation (PRXL)

Creative Planning decreased its position in shares of PAREXEL International Corporation (NASDAQ:PRXL) by 14.7% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,035 shares of the medical research company’s stock after selling 694 shares during the period. Creative Planning’s holdings in PAREXEL International Corporation were worth $351,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of PRXL. Public Employees Retirement System of Ohio boosted its position in shares of PAREXEL International Corporation by 4.5% in the first quarter. Public Employees Retirement System of Ohio now owns 1,713 shares of the medical research company’s stock worth $108,000 after buying an additional 73 shares during the last quarter. Meadow Creek Investment Management LLC boosted its position in shares of PAREXEL International Corporation by 7.1% in the first quarter. Meadow Creek Investment Management LLC now owns 1,980 shares of the medical research company’s stock worth $125,000 after buying an additional 132 shares during the last quarter. Baird Financial Group Inc. boosted its position in shares of PAREXEL International Corporation by 2.3% in the first quarter. Baird Financial Group Inc. now owns 5,812 shares of the medical research company’s stock worth $367,000 after buying an additional 133 shares during the last quarter. Isthmus Partners LLC boosted its position in shares of PAREXEL International Corporation by 1.3% in the first quarter. Isthmus Partners LLC now owns 11,516 shares of the medical research company’s stock worth $727,000 after buying an additional 145 shares during the last quarter. Finally, Capstone Asset Management Co. boosted its position in shares of PAREXEL International Corporation by 3.8% in the first quarter. Capstone Asset Management Co. now owns 4,409 shares of the medical research company’s stock worth $278,000 after buying an additional 160 shares during the last quarter. 91.58% of the stock is owned by institutional investors.

Shares of PAREXEL International Corporation (NASDAQ:PRXL) opened at 87.66 on Friday. PAREXEL International Corporation has a one year low of $51.16 and a one year high of $87.86. The firm’s 50-day moving average price is $87.43 and its 200 day moving average price is $74.60. The company has a market capitalization of $4.45 billion, a PE ratio of 38.53 and a beta of 0.79.

TRADEMARK VIOLATION WARNING: “Creative Planning Has $351,000 Stake in PAREXEL International Corporation (PRXL)” was posted by Community Financial News and is the property of of Community Financial News. If you are reading this report on another website, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The original version of this report can be read at https://www.com-unik.info/2017/08/19/parexel-international-corporation-prxl-stake-cut-by-creative-planning-updated-updated.html.

A number of research analysts have issued reports on the company. Zacks Investment Research raised PAREXEL International Corporation from a “hold” rating to a “buy” rating and set a $98.00 price objective for the company in a report on Saturday. Barclays PLC cut PAREXEL International Corporation from an “overweighr” rating to an “equal weight” rating and set a $87.00 price objective for the company. in a report on Tuesday, June 20th. Jefferies Group LLC reissued a “hold” rating and set a $88.10 price objective on shares of PAREXEL International Corporation in a report on Wednesday, June 21st. Raymond James Financial, Inc. raised PAREXEL International Corporation from an “underperform” rating to a “mkt perform” rating in a report on Tuesday, June 20th. Finally, BidaskClub cut PAREXEL International Corporation from a “strong-buy” rating to a “buy” rating in a report on Friday, July 28th. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating and four have issued a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $75.93.

About PAREXEL International Corporation

PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries.

Institutional Ownership by Quarter for PAREXEL International Corporation (NASDAQ:PRXL)

What are top analysts saying about PAREXEL International Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for PAREXEL International Corporation and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit